UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3390) 3390
Book Chapter (10) 10
Magazine Article (5) 5
Newsletter (5) 5
Dissertation (3) 3
Newspaper Article (3) 3
Publication (3) 3
Book / eBook (2) 2
Book Review (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2754) 2754
humans (2711) 2711
life sciences & biomedicine (2694) 2694
citalopram - therapeutic use (2129) 2129
male (2069) 2069
female (1969) 1969
psychiatry (1651) 1651
adult (1494) 1494
middle aged (1265) 1265
citalopram (1250) 1250
serotonin uptake inhibitors - therapeutic use (1164) 1164
pharmacology & pharmacy (1067) 1067
neurosciences & neurology (968) 968
treatment outcome (925) 925
antidepressants (895) 895
neurosciences (791) 791
aged (770) 770
depressive disorder, major - drug therapy (761) 761
citalopram - adverse effects (676) 676
antidepressive agents, second-generation - therapeutic use (612) 612
antidepressive agents - therapeutic use (610) 610
depression (581) 581
citalopram - pharmacology (552) 552
double-blind method (536) 536
clinical neurology (527) 527
adolescent (495) 495
animals (495) 495
escitalopram (446) 446
serotonin uptake inhibitors - adverse effects (428) 428
serotonin (420) 420
depressive disorder - drug therapy (417) 417
citalopram - administration & dosage (404) 404
psychiatric status rating scales (398) 398
serotonin uptake inhibitors (375) 375
serotonin uptake inhibitors - pharmacology (375) 375
depression, mental (368) 368
mental depression (362) 362
young adult (360) 360
depression - drug therapy (356) 356
drug therapy (355) 355
psychology (326) 326
social sciences (315) 315
dose-response relationship, drug (276) 276
drug therapy, combination (264) 264
major depressive disorder (264) 264
rats (261) 261
depressive disorder, major - psychology (243) 243
serotonin uptake inhibitors - administration & dosage (242) 242
abridged index medicus (238) 238
analysis (238) 238
severity of illness index (237) 237
time factors (237) 237
mental disorders (225) 225
clinical trials (218) 218
research (218) 218
aged, 80 and over (210) 210
antidepressive agents, second-generation - adverse effects (206) 206
fluoxetine (203) 203
care and treatment (197) 197
psychology, clinical (183) 183
ssri (183) 183
antidepressant (181) 181
risk factors (181) 181
health aspects (171) 171
antidepressive agents - adverse effects (170) 170
depressive disorder, major - diagnosis (170) 170
paroxetine (170) 170
sertraline (168) 168
pharmacology (163) 163
drugs (158) 158
anxiety disorders - drug therapy (157) 157
anxiety (156) 156
pharmacology/toxicology (154) 154
drug administration schedule (153) 153
antidepressive agents - pharmacology (152) 152
fluoxetine - therapeutic use (152) 152
paroxetine - therapeutic use (152) 152
follow-up studies (150) 150
internal medicine (150) 150
drug interactions (149) 149
sertraline - therapeutic use (149) 149
dosage and administration (148) 148
general & internal medicine (148) 148
mice (146) 146
prospective studies (146) 146
medicine, general & internal (144) 144
medicine & public health (138) 138
randomized controlled trials as topic (138) 138
citalopram - pharmacokinetics (136) 136
venlafaxine hydrochloride (135) 135
neurology (134) 134
serotonin - metabolism (132) 132
child (131) 131
psychopharmacology (131) 131
comorbidity (129) 129
biomedicine (128) 128
rats, sprague-dawley (128) 128
depressive disorder - psychology (124) 124
brain - drug effects (122) 122
brain (119) 119
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3331) 3331
German (35) 35
French (28) 28
Russian (24) 24
Spanish (8) 8
Polish (7) 7
Portuguese (7) 7
Italian (6) 6
Chinese (5) 5
Swedish (5) 5
Danish (4) 4
Dutch (4) 4
Czech (2) 2
Hebrew (2) 2
Hungarian (2) 2
Finnish (1) 1
Icelandic (1) 1
Korean (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2004, Volume 18, Issue 14, 22
..., with onset in the first 3 years of life. As part of a multimodal approach that includes educational and behavioural interventions, appropriate use of pharmacotherapy in patients with PDDs can improve some symptoms and behaviours... 
Citalopram, therapeutic use | Clozapine, therapeutic use | Venlafaxine, therapeutic use | Amantadine, therapeutic use | Buspirone, therapeutic use | Ziprasidone, therapeutic use | Fluoxetine, therapeutic use | Pyridoxine, therapeutic use | Antipsychotics, therapeutic use | Valproate semisodium, therapeutic use | Naltrexone, therapeutic use | Niaprazine, therapeutic use | Clonidine, therapeutic use | Antidepressants, therapeutic use | Secretin, therapeutic use | Olanzapine, therapeutic use | Quetiapine, therapeutic use | Sertraline, therapeutic use | Lithium, therapeutic use | Paroxetine, therapeutic use | Mirtazapine, therapeutic use | Clomipramine, therapeutic use | Pervasive developmental disorders, treatment | Guanfacine, therapeutic use | Methylphenidate, therapeutic use | Fluvoxamine, therapeutic use | Risperidone, therapeutic use | Lamotrigine, therapeutic use | Pharmacotherapy | Neurology | Neurosciences | Medicine & Public Health | Psychiatry | Psychopharmacology | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Psychotropic Drugs - adverse effects | Developmental Disabilities - drug therapy | Antipsychotic Agents - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Adolescent | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Clinical Trials as Topic | Child | Developmental Disabilities - psychology | Psychotropic Drugs - therapeutic use | Index Medicus
Book Review
Journal Article
Current medicinal chemistry, ISSN 0929-8673, 04/2012, Volume 19, Issue 12, pp. 1846 - 1863
New-generation antidepressants are a heterogeneous class of drugs used in the treatment of depression and related disorders. This review deals with the first... 
Paroxetine | Antidepressants | Fluoxetine | Pharmacological properties | Selective serotonin reuptake inhibitors (SSRIs) | Therapeutic drug monitoring (TDM) | Vilazodone | Fluvoxamine | Sertraline | Chemical-clinical correlations | Citalopram | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Paroxetine - pharmacokinetics | Serotonin Uptake Inhibitors - pharmacokinetics | Fluoxetine - pharmacokinetics | Humans | Citalopram - adverse effects | Depressive Disorder - drug therapy | Paroxetine - therapeutic use | Sertraline - adverse effects | Paroxetine - adverse effects | Benzofurans - pharmacokinetics | Sertraline - pharmacokinetics | Vilazodone Hydrochloride | Sertraline - therapeutic use | Fluoxetine - therapeutic use | Piperazines - pharmacokinetics | Fluoxetine - adverse effects | Fluvoxamine - therapeutic use | Benzofurans - therapeutic use | Serotonin Uptake Inhibitors - therapeutic use | Fluvoxamine - pharmacokinetics | Serotonin Uptake Inhibitors - adverse effects | Piperazines - therapeutic use | Benzofurans - adverse effects | Depressive Disorder - metabolism | Fluvoxamine - adverse effects | Piperazines - adverse effects | Indoles - adverse effects | Citalopram - pharmacokinetics | Citalopram - therapeutic use | Indoles - pharmacokinetics | Indoles - therapeutic use | Drug Monitoring
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2017, Volume 2019, Issue 10, pp. CD012535 - CD012535
Background Pain is a common feature of childhood and adolescence around the world, and for many young people, that pain is chronic. The World Health... 
2019 3.6 All/Other/Non‐cancer chronic pain | Amines | Management in children | Gabapentin | Dyspepsia | Abdominal Pain | Antidepressive Agents | 2019 3. Chronic pain | Citalopram | Analgesics | Chronic non‐cancer pain management | Irritable Bowel Syndrome | Child health | Placebos | Pharmacological therapies | Management and prevention of chronic non‐cancer pain in children | Chronic Pain | gamma‐Aminobutyric Acid | Amitriptyline | Complex Regional Pain Syndromes | Pain & anaesthesia | Randomized Controlled Trials as Topic | Chronic non‐cancer pain | Cyclohexanecarboxylic Acids | Neuralgia | Medicine General & Introductory Medical Sciences | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Citalopram - adverse effects | Placebos - therapeutic use | Amines - therapeutic use | Amines - adverse effects | gamma-Aminobutyric Acid - therapeutic use | Child | Analgesics - adverse effects | gamma-Aminobutyric Acid - adverse effects | Analgesics - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Dyspepsia - drug therapy | Chronic Pain - drug therapy | Cyclohexanecarboxylic Acids - adverse effects | Irritable Bowel Syndrome - drug therapy | Abdominal Pain - drug therapy | Neuralgia - drug therapy | Antidepressive Agents - therapeutic use | Adolescent | Amitriptyline - adverse effects | Citalopram - therapeutic use | Amitriptyline - therapeutic use | Antidepressive Agents - adverse effects | Complex Regional Pain Syndromes - drug therapy | Index Medicus
Journal Article
Journal of clinical psychopharmacology, ISSN 0271-0749, 04/2008, Volume 28, Issue 2, pp. 156 - 165
Journal Article
The international journal of neuropsychopharmacology, ISSN 1469-5111, 10/2019, Volume 22, Issue 10, pp. 616 - 630
Journal Article